Supports early-stage California investigators in conducting innovative pilot studies in basic biomedical and translational HIV research, emphasizing discovery, clinical relevance, and mentorship.
Funder: University of California
Due Dates: May 1, 2026 (Questions Due) | May 14, 2026 (LOI Due, 12:00 Noon) | July 9, 2026 (Full Application Due, 12:00 Noon)
Funding Amounts: Up to $200,000 in direct costs over 2 years (plus up to 40% indirects); possible $10,000 student/trainee supplement after year 1.
Summary: Supports early-stage investigators in California to conduct innovative HIV-related basic biomedical and translational pilot studies.
Key Information: Only the top 20 LOIs will be invited to submit full applications; PI must be ESI by NIH and CHRP criteria and have a mentor.
This funding opportunity supports early-stage investigators (ESIs) in California to conduct pilot studies in HIV-related basic biomedical and translational research. The goal is to enable innovative, high-risk projects that can generate preliminary data for larger grants and advance new tools for HIV prevention, treatment, and cure. The program emphasizes mentoring, career development, and a strong focus on laboratory-based discovery and translation to clinical relevance.